SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-10-002168
Filing Date
2010-05-28
Accepted
2010-05-28 15:26:26
Documents
10
Period of Report
2010-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_37820.htm 8-K 44319
2 EX-3.1 exhibit1.htm EX-3.1 106938
3 EX-10.1 exhibit2.htm EX-10.1 139225
4 EX-10.2 exhibit3.htm EX-10.2 47254
5 EX-10.3 exhibit4.htm EX-10.3 43174
6 EX-10.4 exhibit5.htm EX-10.4 43195
7 EX-10.5 exhibit6.htm EX-10.5 44576
8 EX-10.6 exhibit7.htm EX-10.6 17057
9 EX-10.7 exhibit8.htm EX-10.7 43553
10 EX-10.8 exhibit9.htm EX-10.8 16977
  Complete submission text file 0001299933-10-002168.txt   548036
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 10866578
SIC: 2836 Biological Products, (No Diagnostic Substances)